Dr. Mark Hyman Talks About Arterosil HP

Posted by Calroy Health Sciences on Jul 6, 2022 2:39:40 PM

 

A Tool for Vascular Health

With over a million online followers, and 14 New York Times bestselling books, Dr. Mark Hyman is one of the best-known practitioners of functional medicine. In this short video clip, he emphasizes the current crisis in cardiometabolic health and explains why he recommends Arterosil HP as an important addition to the clinical toolkit.

Mark Hyman, MD, is founder and director of The UltraWellness Center, the Head of Strategy and Innovation of the Cleveland Clinic Center for Functional Medicine, and Board President for Clinical Affairs for The Institute for Functional Medicine. He is the host of one of the leading health podcasts, The Doctor’s Farmacy.

Key Takeaways:

  • Almost 90% of Americans have some form of cardiometabolic disorder
  • Managing stress and getting adequate sleep are among the key lifestyle factors
  • Natural products can play an important role in mitigating poor diet
  • Arterosil HP is patented to stabilize and regress vulnerable plaque (U.S. Patent #11,135,238; International Patents Pending)

“One of the natural products is called Arterosil, which is a patented compound that's been shown in clinical trials to stabilize and reverse vulnerable plaque in humans, which I think is a great advance and is a wonderful overall part of a management program that you can use with your patients.” - Dr. Hyman

To learn more about upstream vascular interventions, watch a short presentation by Kristine Burke, MD.

Video: Dr. Kristine Burke on the Glycocalyx

IMPORTANT NOTICE:
The information on this webpage is for licensed healthcare practitioner education only, and is not to be disseminated to the general public.

Topics: Mark Hyman, MD

Arterosil Research Summary 

Free Download 

Numerous cellular, animal and human studies have been conducted to evaluate the biological activities, mode of mechanisms, and therapeutic benefits of Arterosil, a patent-pending nutraceutical. Studies include:

  • MRI Carotid Plaque Regression Study
  • Glycocalyx Regeneration Study
  • Leukocyte Adhesion Study
  • Arterial Elasticity Study
  • Hypertension Study

Download Arterosil's Research Summary here.

Subscribe Here!

Recent Posts